New stock news: Youcare Pharmaceutical Group(688658.SH) filed documents to Hong Kong Stock Exchange.
According to the disclosure by the Hong Kong Stock Exchange on December 29th, Yuekang Pharmaceutical Group Co., Ltd. (referred to as Yuekang Pharmaceutical (688658.SH)) has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with CITIC Securities as its sole sponsor.
According to the disclosure of the Hong Kong Stock Exchange on December 29, Youcare Pharmaceutical Group Limited (referred to as: Youcare Pharmaceutical Group (688658.SH)) has submitted its listing application to the main board of the Hong Kong Stock Exchange, with CITIC SEC as its exclusive sponsor. The prospectus disclosed that Youcare Pharmaceutical Group is a biopharmaceutical company focusing on research, development, production, and commercialization of four types of therapies: oligonucleotides, messenger ribonucleic acid (mRNA) vaccines, peptides, and traditional Chinese medicine innovative drugs. The company utilizes a combination of commercialized product portfolio, cross-modal R&D technology platform and capabilities, production systems certified with Good Manufacturing Practice (GMP), and a nationwide commercialization network to advance candidate products in major therapeutic areas with high unmet needs and long-term growth potential through differentiated innovative pipelines.
Related Articles
CITIC SEC: Although the registration certificate for collagen has not yet reached its maximum, the current industry is still in a period of dividends.
HONG WEI ASIA (08191) will be temporarily suspended from trading starting from December 30th, reasons for the suspension are yet to be announced.
CITIC SEC: Profitability in the iron-lithium industry is expected to reach a cyclical turning point, recommending top iron-lithium enterprises.
CITIC SEC: Although the registration certificate for collagen has not yet reached its maximum, the current industry is still in a period of dividends.
HONG WEI ASIA (08191) will be temporarily suspended from trading starting from December 30th, reasons for the suspension are yet to be announced.
CITIC SEC: Profitability in the iron-lithium industry is expected to reach a cyclical turning point, recommending top iron-lithium enterprises.
